To direct the Food and Drug Administration to solicit and consider the recommendations of the Vaccines and Related Biological Products Advisory Committee before taking certain actions with respect to COVID-19 vaccines, and for other purposes.
About This Bill
Committee
Latest Action · August 7, 2020
Referred to the House Committee on Energy and Commerce.
Expeditious Vaccine Advice with Legitimate, Unbiased, Apolitical, and Technical Expertise Act or the EVALUATE Act
This bill requires the Food and Drug Administration, before licensing or authorizing any COVID-19 (i.e., coronavirus disease 2019) vaccine, to receive advisory committee recommendations concerning the vaccine's safety and effectiveness.
Take Action
Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.